Perspectives on the management of coronary artery disease in India

Ganesan Karthikeyan1, Denis Xavier, Doriaraj Prabhakaran

  • 1Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.

Insights

Cardiovascular disease (CVD) management in India is highly inconsistent, with significant disparities in care access and quality. Addressing this requires documenting practices, disseminating resource-sensitive guidelines, and promoting public awareness and healthy lifestyles.

Area of Science:

  • Public Health
  • Cardiology
  • Health Services Research

Background:

  • Cardiovascular disease (CVD) management in India exhibits significant heterogeneity.
  • Care quality varies dramatically, from evidence-based treatments in tertiary centers to inadequate care due to limited access in other regions.

Purpose of the Study:

  • To highlight the imbalance in cardiovascular disease (CVD) patient care across India.
  • To identify strengths and weaknesses in the current healthcare system for CVD management.
  • To propose strategies for improving CVD care delivery nationwide.

Main Methods:

  • Documenting practice patterns in representative Indian hospitals across different regions.
  • Analyzing the accessibility and quality of specialist care for cardiovascular disease (CVD) patients.
  • Assessing the current dissemination of evidence-based and cost-effective treatment guidelines.

Main Results:

  • Significant disparities exist in cardiovascular disease (CVD) management, with a clear divide between well-resourced and under-resourced healthcare settings.
  • Lack of access to specialist care contributes to suboptimal treatment outcomes for many patients.
  • Current guidelines and public awareness initiatives for CVD are insufficient to address the heterogeneity in care.

Conclusions:

  • There is a critical need to address the imbalance in cardiovascular disease (CVD) care across India.
  • Disseminating resource-sensitive, evidence-based guidelines and enhancing public health awareness are crucial steps.
  • Promoting healthy lifestyles and discouraging unhealthy habits are essential for mitigating the CVD burden.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...